BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2504591)

  • 1. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on the pharmacokinetics of ciprofloxacin.
    Nilsson-Ehle I; Ljungberg B
    Scand J Infect Dis Suppl; 1989; 60():23-7. PubMed ID: 2756350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ciprofloxacin in the elderly.
    Bayer A; Gajewska A; Stephens M; Stark JM; Pathy J
    Respiration; 1987; 51(4):292-5. PubMed ID: 3659579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.
    Hirata CA; Guay DR; Awni WM; Stein DJ; Peterson PK
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1927-31. PubMed ID: 2610503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ciprofloxacin in ponies.
    Dowling PM; Wilson RC; Tyler JW; Duran SH
    J Vet Pharmacol Ther; 1995 Feb; 18(1):7-12. PubMed ID: 7752310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs.
    Nouws JF; Mevius DJ; Vree TB; Baars AM; Laurensen J
    Vet Q; 1988 Jul; 10(3):156-63. PubMed ID: 3176294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oral ciprofloxacin in healthy, young Brazilian subjects.
    Sudo RT; Melo PA; Suarez-Kurtz G
    Braz J Med Biol Res; 1990; 23(12):1315-21. PubMed ID: 2136565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
    Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
    Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses.
    Lettieri JT; Rogge MC; Kaiser L; Echols RM; Heller AH
    Antimicrob Agents Chemother; 1992 May; 36(5):993-6. PubMed ID: 1510426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption.
    Ljungberg B; Nilsson-Ehle I; Edlund C; Nord CE
    Scand J Infect Dis; 1990; 22(2):205-8. PubMed ID: 2356443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacokinetics of ciprofloxacin in patients with renal function of various degrees].
    Yu H; Wang HY; Sun ZM
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):449-51. PubMed ID: 7867438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ciprofloxacin in elderly subjects.
    LeBel M; Barbeau G; Bergeron MG; Roy D; Vallée F
    Pharmacotherapy; 1986; 6(2):87-91. PubMed ID: 2940518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
    Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly.
    Oberbauer R; Krivanek P; Turnheim K
    Clin Pharmacol Ther; 1995 Jan; 57(1):42-51. PubMed ID: 7828380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative bioavailability of two brands of ciprofloxacin: an Indian study.
    Suthakaran C; Rajaram S; Adithan C
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):66-8. PubMed ID: 1551749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice.
    Liu XG; Li RC
    J Chemother; 2001 Oct; 13(5):563-8. PubMed ID: 11760222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.